The Boston Globe
World Cup 2026: England squad discusses Tuchel's tactics ahead of match against Argentina
Heat Wave Expected to Break Soon as Canadian Wildfire Smoke Causes Unhealthy Air Quality
_1777370193195_831968492.png&w=48&q=75){kind=small}
Company One continues Boston women's suffrage play series to promote women’s rights awareness
Poll shows Americans believe Trump will not secure a better Iran deal than Obama did
_1777370220974_847775619.png&w=48&q=75){kind=small}
Everything You Need to Know About the 2023 World Cup Final
المصدر: The Boston Globe
24 Hrsجاهز للتشغيل
جاهز للتشغيل
The FDA approved the oral drug Lipfendra, manufactured by Merck, which significantly lowers LDL cholesterol levels by targeting PCSK9. Clinical trials show it reduces LDL by up to 60% with similar safety to existing injectable PCSK9 inhibitors. The pill will cost $315 for a 30-day supply and is expected to improve access for high-risk patients, potentially reducing heart attack and stroke risks. Merck plans to make it widely available in a few weeks.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading